A longitudinal analysis of the economic cost of all phases of TB care in a low incidence setting
Ramsay LC, Brode SK, Rea E, Barrett K, Hernandez A, Iragorri N, Liu K, Macdonald L, Sander B. IJTLD Open. 2025; 2(7):404-411.
Publications
The burden of antimicrobial resistant bacteremia in Ontario: a population-wide analysis of attributable mortality from 110 pathogen-antibiotic combinations
Brown KA, Fridman DJ, Garber GE, Johnstone J, Langford BJ, Leung V, MacFadden D, Patel SN, Schwartz KL, Sander B, Daneman N. Clin Infect Dis. 2025; ciaf213 Epub 2025 May 13.
Social inequalities in COVID-19 death by area-level income in 11.2 million people in Ontario, Canada: patterns over time and the mediating role of vaccination
Wang L, Swayze S, Bodner K, Calzavara A, Harrigan SP, Siddiqi A, Baral SD, Austin PC, Smylie J, Koh M, Sbihi H, Sander B, Kwong JC, Mishra S. Am J Epidemiol. 2025; Mar 7 [Epub ahead of print].
The association of combinations of social factors and SARs-CoV-2 infection: a retrospective population-based cohort study in Ontario, 2020–2021
Persaud S, Fitzgerald M, Hawken S, Tanuseputro P, Boucher L, Petrcich W, Wellman M, Webber C, Shoemaker E, Ducharme R, Dahrouge S, Myran D, Bayoumi AM, Wanigaratne S, Bloch G, Ponka D, Smith BT, Lofters A, Zygmunt A, Kehoe MacLeod K, Turcotte LA, Sander B, Howard M, Funnell S, Rayner J, Kitagawa K, Ibrahim S, Kendall CE. Dialogues Health. 2024; (5)100197.
The association of combinations of social factors and SARs-CoV-2 infection: a retrospective population-based cohort study in Ontario, 2020-2021
Persaud S, Fitzgerald M, Hawken S, Tanuseputro P, Boucher L, Petrcich W, Wellman M, Webber C, Shoemaker E, Ducharme R, Dahrouge S, Myran D, Bayoumi AM, Wanigaratne S, Bloch G, Ponka D, Smith BT, Lofters A, Zygmunt A, MacLeod KK, Turcotte LA, Sander B, Howard M, Funnell S, Rayner J, Kitagawa K, Ibrahim S, Kendall CE. Dialogues Health. 2024; 5:100197.
Burden of infant group B Streptococcus disease and impact of maternal screening and antibiotic prophylaxis in Ontario, Canada: a population-based cohort study
Fakhraei R, Fell DB, El-Chaâr D, Thampi N, Sander B, Brown KA, Crowcroft N, Bolotin S, Barrett J, Darling EK, Fittipaldi N, Lamagni T, McGeer A, Murti M, Sadarangani M, Schwartz KL, Yasseen A, Tunis M, Petrcich W, Wilson K. Lancet Reg Health Am. 2024; 39:100914.
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada
Greenwald ZR, Werb D, Feld JJ, Austin PC, Fridman D, Bayoumi AM, Gomes T, Kendall CE, Lapointe-Shaw L, Scheim AI, Bartlett SR, Benchimol EI, Bouck Z, Boucher LM, Greenaway C, Janjua NZ, Leece P, Wong WWL, Sander B, Kwong JC. J Clin Epidemiol. 2024; Mar 22 [Epub ahead of print].
Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection
Forouzannia F, Hamadeh A, Passos-Castilho AM, Erman A, Yu A, Feng Z, Janjua NZ, Sander B, Greenaway C, Wong WWL. Liver Int. 2024; Mar 6 [Epub ahead of print].
Hepatitis C attributable healthcare costs and mortality among immigrants: a population-based matched cohort study
Erman A, Sahakyan Y, Everett K, Greenaway C, Janjua N, Kwong JC, Wong WWL, Lu H, Sander B. Can J Gastroenterol Hepatol. 2024; Feb 24 [Epub ahead of print].
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: an interrupted time series analysis
Zeitouny S, Cheung DC, Bremner KE, Pataky RE, Pequeno P, Matelski J, Peacock S, Del Giudice ME, Lapointe-Shaw L, Tomlinson G, Mendlowitz AB, Mulder C, Tsui TCO, Perlis N, Walker JD, Sander B, Wong WWL, Krahn MD, Kulkarni GS. PLoS One. 2023; 18(9):e0290646. Epub 2023 Sep 8.